International Flavors & Fragrances, Inc.
 
 
 
 
公司概覽
業務類別 Specialty Chemicals
業務概覽 International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. Through its taste and scent segments, which each generate around 25% of profits, IFF is a leading flavor and fragrances producer. The health and biosciences business, which generates 30% of profits, is a global leader in probiotics and enzymes. The remaining profits come from the food ingredients business, which sells texturants, plant-based proteins, and other ingredients, though IFF plans to divest this business in the future.
公司地址 521 West 57th Street, New York, NY, USA, 10019-2960
電話號碼 +1 212 765-5500
傳真號碼 --
公司網頁 https://www.iff.com
員工數量 21500
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Yuvraj Arora President, Taste and Chief Commercial Officer 美元 695.30K 27/02/2026
Dr. Casper Vroemen Executive Vice President, Chief Research and Development Officer -- 28/02/2024
Ms. Ana Paula Teles de Mendonca President, Scent -- 27/02/2026
Mr. Stephen N. Landsman Executive Vice President and General Counsel -- 27/02/2026
Mr. Michael DeVeau Executive Vice President and Chief Financial Officer -- 27/02/2026
Mr. Ralf Finzel Executive Vice President and Global Operations Officer -- 27/02/2026
Mr. Vivek Verma Executive Vice President and Chief Information Officer -- 27/02/2026
Dr. Angela Strzelecki, B.S. President, Pharma Solutions -- 28/02/2025
Mr. Marc H. Birenkrant Controller and Chief Accounting Officer -- 27/02/2026
Ms. Deborah Borg Executive Vice President and Chief People and Culture Officer -- 27/02/2026
Ms. Leticia Goncalves Lourenco President, Health and Biosciences -- 27/02/2026
Mr. Andres Roberto Muller President, Food Ingredients -- 27/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Brett M. Icahn Independent Director 27/02/2026
Mr. Jon Erik Fyrwald Director and Chief Executive Officer 27/02/2026
Dr. Richard C. Mulligan, PhD Independent Director 27/02/2026
Ms. Cynthia T. Jamison Independent Director 27/02/2026
Mr. Kevin O'Byrne Chairman of the Board 27/02/2026
Mr. John F. Ferraro Independent Director 27/02/2026
Ms. Virginia C. Drosos Independent Director 27/02/2026
Dr. Kathryn Jean Boor, PhD Independent Director 27/02/2026
Mr. Paul J. Fribourg Independent Director 27/02/2026
Dr. Mehmood Khan Independent Director 27/02/2026
Ms. Dawn C. Willoughby Independent Director 27/02/2026
Mr. Mark J. Costa Independent Director 27/02/2026
Mr. Jesus B. Mantas Independent Director 27/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:19)
代號 名稱 佔比% 持有日期
IWViShares Russell 3000 ETF0.03%28/02/2026
VOOVVanguard S&P 500 Value ETF0.02%31/01/2026
DFAUDimensional US Core Equity Market ETF0.02%27/02/2026
BSMCBrandes U.S. Small-Mid Cap Value ETF0.02%26/02/2026
BUSABrandes U.S. Value ETF0.02%26/02/2026
ESGVVanguard ESG US Stock ETF0.02%31/01/2026
SPTMState StreetSPDRPortS&P1500CompStkMktETF0.02%27/02/2026
GSEWGoldman Sachs Equal Wght US Lg Cp Eq ETF0.02%27/02/2026
GSLCGoldman Sachs ActiveBeta® US LgCp Eq ETF0.02%27/02/2026
VONEVanguard Russell 1000 ETF0.02%31/01/2026
AVUSAvantis US Equity ETF0.02%28/02/2026
DSIiShares ESG MSCI KLD 400 ETF0.02%28/02/2026
EUSAiShares MSCI USA Equal Weighted ETF0.01%28/02/2026
IMCViShares Morningstar Mid-Cap Value ETF0.01%28/02/2026
SMOTVanEck Morningstar SMID Moat ETF0.01%28/02/2026
BBUSJPMorgan BetaBuilders US Equity ETF0.01%27/02/2026
MXIiShares Global Materials ETF0.01%28/02/2026
GABGabelli Equity Trust0.01%31/12/2025
EQALInvesco Russell 1000 Equal Weight ETF0.01%27/02/2026
IMCBiShares Morningstar Mid-Cap ETF0.01%28/02/2026
  1    2   3    4    5    6    7    8    9    10    11    12  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.